- Fulgent Genetics (NASDAQ:FLGT) extended its partnership with the New York City Department of Education and NYC Health + Hospitals for COVID-19 testing through the remainder of the 2021 school year.
- Under the agreement, Fulgent will provide COVID-19 testing for students and employees at many K-12 schools in New York City on a daily basis.
- The testing program utilizes Fulgent's in-house built Enterprise Platform to make the testing process very fast and easy to scale.
- Shares +4.5% premarket.
Fulgent Genetics extends partnership with New York City schools; awarded contract for 2021 school year
Recommended For You
About FLGT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
FLGT | - | - |
Fulgent Genetics, Inc. |